Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: Report of a pilot study

D. Clapp, Robert M. Kliegman, Jill E. Baley, Nancy Shenker, Kay Kyllonen, Avroy A. Fanaroff, Melvin Berger

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

To evaluate the use of intravenously administered immune globulin (IVIG) for prevention of sepsis in preterm infants, we administered IVIG in a protocol designed to maintain a therapeutic serum "larget level" of 700 mg/dl. The 200 patients who were ellgible for the study (600 to 2000 gm birth weight) were monitored throughout their initial hospitalization. Of these, 115 patients were randomly assigned in a double-blind, controlled trial to treatment and placebo groups. The remaining 85 infants were not randomly assigned to a group, by parental request, but were followed and analyzed separately. In one patient who received IVIG, transient tachycardia and a decrease in blood pressure developed during an infusion; resolution occurred promptly after the infusion was discontinued. No persistent hepatic or renal abnormalities were noted in either the IVIG- or the placebo-treated group. There were seven episodes of sepsis in the placebo group and nine in the group whose parents refused consent to the study. No infant who received IVIG acquired nosocomial sepsis (p

Original languageEnglish (US)
Pages (from-to)973-978
Number of pages6
JournalJournal of Pediatrics
Volume115
Issue number6
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Low Birth Weight Infant
Immunoglobulins
Sepsis
Placebos
Birth Weight
Premature Infants
Tachycardia
Hospitalization
Parents
Blood Pressure
Kidney
Liver
Therapeutics
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants : Report of a pilot study. / Clapp, D.; Kliegman, Robert M.; Baley, Jill E.; Shenker, Nancy; Kyllonen, Kay; Fanaroff, Avroy A.; Berger, Melvin.

In: Journal of Pediatrics, Vol. 115, No. 6, 1989, p. 973-978.

Research output: Contribution to journalArticle

Clapp, D. ; Kliegman, Robert M. ; Baley, Jill E. ; Shenker, Nancy ; Kyllonen, Kay ; Fanaroff, Avroy A. ; Berger, Melvin. / Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants : Report of a pilot study. In: Journal of Pediatrics. 1989 ; Vol. 115, No. 6. pp. 973-978.
@article{24dea54b030141d48e188daba18adb62,
title = "Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: Report of a pilot study",
abstract = "To evaluate the use of intravenously administered immune globulin (IVIG) for prevention of sepsis in preterm infants, we administered IVIG in a protocol designed to maintain a therapeutic serum {"}larget level{"} of 700 mg/dl. The 200 patients who were ellgible for the study (600 to 2000 gm birth weight) were monitored throughout their initial hospitalization. Of these, 115 patients were randomly assigned in a double-blind, controlled trial to treatment and placebo groups. The remaining 85 infants were not randomly assigned to a group, by parental request, but were followed and analyzed separately. In one patient who received IVIG, transient tachycardia and a decrease in blood pressure developed during an infusion; resolution occurred promptly after the infusion was discontinued. No persistent hepatic or renal abnormalities were noted in either the IVIG- or the placebo-treated group. There were seven episodes of sepsis in the placebo group and nine in the group whose parents refused consent to the study. No infant who received IVIG acquired nosocomial sepsis (p",
author = "D. Clapp and Kliegman, {Robert M.} and Baley, {Jill E.} and Nancy Shenker and Kay Kyllonen and Fanaroff, {Avroy A.} and Melvin Berger",
year = "1989",
doi = "10.1016/S0022-3476(89)80753-X",
language = "English (US)",
volume = "115",
pages = "973--978",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants

T2 - Report of a pilot study

AU - Clapp, D.

AU - Kliegman, Robert M.

AU - Baley, Jill E.

AU - Shenker, Nancy

AU - Kyllonen, Kay

AU - Fanaroff, Avroy A.

AU - Berger, Melvin

PY - 1989

Y1 - 1989

N2 - To evaluate the use of intravenously administered immune globulin (IVIG) for prevention of sepsis in preterm infants, we administered IVIG in a protocol designed to maintain a therapeutic serum "larget level" of 700 mg/dl. The 200 patients who were ellgible for the study (600 to 2000 gm birth weight) were monitored throughout their initial hospitalization. Of these, 115 patients were randomly assigned in a double-blind, controlled trial to treatment and placebo groups. The remaining 85 infants were not randomly assigned to a group, by parental request, but were followed and analyzed separately. In one patient who received IVIG, transient tachycardia and a decrease in blood pressure developed during an infusion; resolution occurred promptly after the infusion was discontinued. No persistent hepatic or renal abnormalities were noted in either the IVIG- or the placebo-treated group. There were seven episodes of sepsis in the placebo group and nine in the group whose parents refused consent to the study. No infant who received IVIG acquired nosocomial sepsis (p

AB - To evaluate the use of intravenously administered immune globulin (IVIG) for prevention of sepsis in preterm infants, we administered IVIG in a protocol designed to maintain a therapeutic serum "larget level" of 700 mg/dl. The 200 patients who were ellgible for the study (600 to 2000 gm birth weight) were monitored throughout their initial hospitalization. Of these, 115 patients were randomly assigned in a double-blind, controlled trial to treatment and placebo groups. The remaining 85 infants were not randomly assigned to a group, by parental request, but were followed and analyzed separately. In one patient who received IVIG, transient tachycardia and a decrease in blood pressure developed during an infusion; resolution occurred promptly after the infusion was discontinued. No persistent hepatic or renal abnormalities were noted in either the IVIG- or the placebo-treated group. There were seven episodes of sepsis in the placebo group and nine in the group whose parents refused consent to the study. No infant who received IVIG acquired nosocomial sepsis (p

UR - http://www.scopus.com/inward/record.url?scp=0024314202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024314202&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(89)80753-X

DO - 10.1016/S0022-3476(89)80753-X

M3 - Article

C2 - 2585237

AN - SCOPUS:0024314202

VL - 115

SP - 973

EP - 978

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -